Study of OTO-104 in Subjects With Unilateral Meniere's Disease (Q66407729)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
clinical trial

    Statements

    AVERTS-2 (English)
    0 references
    A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease (English)
    0 references
    21 March 2016
    0 references
    31 August 2017
    0 references
    176
    0 references
    18 year
    0 references
    85 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit